| Treatment of systemic sclerosis and idiopathic pulmonary fibrosis |
2023-3-02 |
2023-9-07 |
|
| Process of making a crystalline edg-2 receptor antagonist |
2023-3-01 |
2023-9-21 |
|
| Process of making a crystalline edg-2 receptor antagonist |
2023-3-01 |
2023-9-07 |
|
| Methods and kits for predicting infusion reaction risk and antibody-mediated … |
2023-2-01 |
2023-8-10 |
|
| Heterocyclic inhibitors of glut9 for treatment of disease |
2023-1-06 |
2023-7-13 |
|
| Methods for the treatment of idiopathic orbital inflammation and related … |
2022-11-21 |
2023-8-31 |
|
| Compositions comprising a tn3 scaffold and methods of using the same |
2022-11-01 |
2023-8-03 |
|
| Reducing immunogenicity to pegloticase |
2022-9-28 |
2023-6-08 |
|
| Compositions and methods of modulating xanthine dehydrogenase |
2022-6-17 |
2022-12-29 |
|
| Variant forms of urate oxidase and use thereof |
2022-4-19 |
2023-2-02 |
|
| Methods for the treatment of thyroid ophthalmopathy |
2022-3-25 |
2022-7-08 |
|
| Methods for the treatment of thyroid eye disease |
2022-3-03 |
2023-9-28 |
|
| Methods for the treatment of thyroid eye disease |
2022-3-03 |
2022-9-09 |
|
| Pegloticase for treatment of gout in renal transplant recipients |
2022-2-18 |
2022-10-13 |
|
| Reducing immunogenicity to pegloticase |
2022-2-09 |
2022-10-13 |
|
| Methods for the treatment of thyroid eye disease |
2021-11-19 |
2022-10-27 |
|
| Methods for the treatment of thyroid eye disease |
2021-11-19 |
2022-10-13 |
|
| Crystalline edg-2 receptor antagonist and methods of making |
2021-8-31 |
2022-3-03 |
|
| Methods of treating gout |
2021-8-10 |
2023-9-28 |
|
| Reducing immunogenicity to pegloticase |
2021-6-01 |
2022-12-29 |
|
| Purification of proteins with cationic surfactant |
2021-5-20 |
2022-3-10 |
|
| Methods of treating systemic sclerosis |
2021-4-02 |
2023-2-08 |
|
| METHODS FOR THE TREATMENT OF SCLERODERMA AND RELATED CONDITIONS |
2021-2-04 |
2022-11-16 |
|
| GLYCOSYLATED ANTIBODIES AGAINST THE INSULIN-LIKE GROWTH FACTOR I RECEPTOR AND … |
2020-12-10 |
2022-3-09 |
|
| Methods for the treatment of thyroid eye disease |
2020-12-10 |
2021-9-16 |
|
| Reducing immunogenicity to pegloticase |
2020-7-29 |
2020-11-12 |
|
| Methods for treating urea cycle disorders |
2020-7-14 |
2021-1-07 |
|
| Treatment of urea cycle disorders in neonates and infants |
2020-4-27 |
2020-12-17 |
|
| Methods of therapeutic monitoring of nitrogen scavenging drugs |
2020-3-10 |
2021-1-07 |
|
| Methods of treating urea cycle disorders |
2020-3-06 |
2020-12-31 |
|
| Tolerization reduces intolerance to pegloticase and prolongs the urate lowering … |
2020-1-30 |
2020-7-30 |
|
| Methods for therapeutic monitoring of phenylacetic acid prodrugs |
2019-8-19 |
2019-12-26 |
|
| Purification of proteins with cationic surfactant |
2019-6-27 |
2020-2-20 |
|
| Procedure for the preparation of 4-phenyl butyrate and uses thereof |
2019-5-07 |
2021-5-25 |
2021-5-25 |
| TREATMENT METHOD USING AMMONIA ARRESTED MEDICINAL SUBSTANCES |
2018-11-21 |
2020-5-29 |
|
| Methods of treatment using ammonia-scavenging drugs |
2018-11-08 |
2019-1-11 |
|
| METHODS OF ADMINISTRATION AND EVALUATION OF NITROGEN SCANNING MEDICINES FOR THE … |
2018-1-25 |
2018-12-12 |
|
| Combination therapies of prednisone and uricase molecules and uses thereof |
2017-11-10 |
2023-3-16 |
|
| Treatment of urea cycle disorders in neonates and infants |
2017-8-23 |
2017-12-07 |
|
| Treatment of pain with topical diclofenac |
2017-5-30 |
2018-8-28 |
2018-8-28 |
| Fluoroquinolone formulations for cystic fibrosis |
2017-2-02 |
2018-12-12 |
|
| Methods of diagnosing, grading, monitoring, and treating hepatic encephalopathy |
2016-8-16 |
2016-12-08 |
|
| Diclofenac topical formulation |
2016-4-06 |
2017-1-10 |
2017-1-10 |
| 3, 5-dihydroxy-4-isopropylstilbene (dhis) as miticidal agent and its … |
2016-2-16 |
2017-8-17 |
|
| Methods for treating urea cycle disorders to prevent hyperammonemic crises by … |
2015-6-02 |
2015-12-10 |
|
| Methods for processing a prescription drug request |
2014-9-30 |
2015-4-02 |
|
| Methods for analyzing cysteamine compositions |
2014-6-17 |
2016-4-27 |
|
| Delayed release cysteamine bead formulation |
2014-6-17 |
2022-1-19 |
|
| Medicaments containing famotidine and ibuprofen and administration of same |
2013-2-15 |
2014-3-06 |
|
| Methods and medicaments for administration of ibuprofen |
2013-2-04 |
2014-1-16 |
|
| Variant Form of Urate Oxidase and Use Thereof |
2012-9-20 |
2013-4-04 |
|
| Stable compositions of famotidine and ibuprofen |
2012-9-14 |
2013-8-06 |
2013-8-06 |
| Methods and compositions comprising at least one α3 βA4 nAChR antagonist or … |
2012-7-19 |
2015-5-26 |
2015-5-26 |
| A variant form of urate oxidase and use thereof |
2011-12-19 |
2012-1-19 |
|
| Oral Pharmaceutical Formulations Containing Non-Steroidal Anti-Inflammatory … |
2009-11-11 |
2010-9-09 |
|
| Dosing and monitoring patients on nitrogen-scavenging drugs |
2009-8-27 |
2010-3-04 |
|
| Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
2009-7-17 |
2010-1-21 |
|
| Treatment of pain with topical diclofenac compounds |
2009-7-10 |
2013-10-01 |
2013-10-01 |
| Oral unit dose form containing ibuprofen and famotidine |
2009-1-11 |
2014-7-31 |
|
| Methods of treatment using ammonia-scavenging drugs |
2009-1-07 |
2017-5-31 |
|
| Pharmaceutical compositions containing famotidine and ibuprofen and having … |
2008-1-23 |
2008-9-12 |
|
| Methods for lowering elevated uric acid levels using intravenous injections of … |
2007-9-07 |
2008-7-03 |
|
| Nsaid dose unit formulations with h2-receptor antagonists and methods of use |
2007-8-29 |
2008-5-29 |
|
| Methods and medicaments for administration of ibuprofen |
2007-7-17 |
2010-4-28 |
|
| Methods and medicaments for administration of ibuprofen |
2007-7-17 |
2012-10-03 |
2012-10-03 |
| Methods for Lowering Elevated Uric Acid Levels Using Intravenous Injections of … |
2006-10-06 |
2007-11-29 |
|
| Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil |
2002-11-15 |
2004-4-01 |
|
| Aggregate-free urate oxidase for preparation of non-immunogenic polymer … |
2000-2-10 |
2004-8-31 |
2004-8-31 |